Skip to content
No picture yet

Inrebic 100 mg – DIN 02502445

Inrebic is Fedratinib Hydrochloride 100 mg (capsule), sold in Canada. It is used for primary myelofibrosis. It is supplied by Bristol-Myers Squibb Canada. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Fedratinib Hydrochloride 100 mg

Brand
Inrebic
Strength
100 mg
Used for
Primary myelofibrosis
Form
Capsule
Manufacturer
Bristol-Myers Squibb Canada
Sold in
Canada
DIN
02502445

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Fedratinib Hydrochloride pills and guides

What is Fedratinib Hydrochloride used for?

Fedratinib Hydrochloride is used for primary myelofibrosis.

Official uses from the US prescribing label

INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).

From the FDA-approved label on DailyMed (published Aug 03, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02502445.
  • It names Inrebic, Fedratinib Hydrochloride 100 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Inrebic by Bristol-Myers Squibb Canada.

In Canada: prescription only.

Ingredients

Active: Fedratinib (Fedratinib Hydrochloride)

Other Fedratinib Hydrochloride pills